2015
DOI: 10.1111/add.13001
|View full text |Cite
|
Sign up to set email alerts
|

Next steps in research on injection initiation incidence and prevention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 17 publications
1
16
0
Order By: Relevance
“…Future research should address the underrepresentation of experiences of particular ethnic, sexual, and gender identities in current research; the role of particular drugs; and identify additional specific pathways linking social and structural factors to individual experiences of injection initiation (10). …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Future research should address the underrepresentation of experiences of particular ethnic, sexual, and gender identities in current research; the role of particular drugs; and identify additional specific pathways linking social and structural factors to individual experiences of injection initiation (10). …”
Section: Discussionmentioning
confidence: 99%
“…Patterns of drug injecting are evolving: injection drug use is increasing in some areas and populations that have historically reported low prevalence (e.g., Sub-Saharan Africa (6), white rural populations in North America (7, 8)). There has long been interest in preventing transitions to drug injecting (9, 10), though the effectiveness of interventions has been limited according to scientific evaluations conducted to date (11). There is therefore a need to further develop understanding of injection drug use initiation to inform interventions and policy responses.…”
Section: Introductionmentioning
confidence: 99%
“…Interventions to prevent the initiation of injection drug use: a systematic review Werb et al [18] 2014 BChange the Cycle^intervention Strike et al [19] 2015 Next steps in research on injection initiation incidence and prevention Bluthenthal and Kral [20] 2015 US NIDA Avant Garde Award: BCombined prevention to reduce initiation into injecting drug use^Forthcoming 2015 US NIDA Avenir Award: BPreventing injecting by modifying existing responses^Werb et al [21] 2015 US NIDA R01: BPreventing injection initiation: the Change the Cycle randomized controlled trial^Forthcoming be persistent [36]. Therefore, preventing transitions into injecting should address both the need to prevent people from seeking out injecting and the need to prevent PWID from initiating others into this behavior.…”
Section: Risk Factors For Injection Initiatesmentioning
confidence: 99%
“…Third, preventing injection initiation will require a reconsideration of the key populations for HIV prevention. Specifically, while PWID are implicated in injection initiation events, research to date has delineated those populations at greatest risk of initiating; these should be meaningfully considered within broader prevention efforts [20]. Fourth, a global strategy to prevent injection will necessarily require multisite investigations to determine how best to optimize prevention strategies to local dynamics and discrete policy environments, including low-, middle-, and upper-income settings.…”
Section: Barriers To Effectively Preventing Injection Initiationmentioning
confidence: 99%
“…Adherence to the social communicability of this condition is further influenced by individual, social, and structural factors (Horyniak et al, 2014; Horyniak et al, 2015; Sherman et al, 2002). As such, in settings experiencing syndemics of IDU and blood-borne disease, calls have been made to prioritize the prevention of injection initiation to reduce disease incidence and mitigate other drug-related harms (Bluthenthal & Kral, 2015; Vlahov, Fuller, Ompad, Galea, & Des Jarlais, 2004; Werb et al, 2016). Preventing injection initiation is likely to be more effective in curtailing the expansion of epidemics of blood-borne disease compared with efforts to reduce injection-related risk behaviors among individuals after they have begun injecting, given that the risk of HIV and hepatitis C virus (HCV) transmission increases dramatically during the months and years immediately postinitiation (Garfein, Vlahov, Galai, Doherty, & Nelson, 1996; Vlahov et al, 2004).…”
Section: Introductionmentioning
confidence: 99%